Eric R. Hugo

2.5k total citations
30 papers, 2.0k citations indexed

About

Eric R. Hugo is a scholar working on Molecular Biology, Physiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Eric R. Hugo has authored 30 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Physiology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Eric R. Hugo's work include Adipose Tissue and Metabolism (9 papers), Growth Hormone and Insulin-like Growth Factors (8 papers) and Adipokines, Inflammation, and Metabolic Diseases (7 papers). Eric R. Hugo is often cited by papers focused on Adipose Tissue and Metabolism (9 papers), Growth Hormone and Insulin-like Growth Factors (8 papers) and Adipokines, Inflammation, and Metabolic Diseases (7 papers). Eric R. Hugo collaborates with scholars based in United States, Chile and United Kingdom. Eric R. Hugo's co-authors include Nira Ben‐Jonathan, Terry D. Brandebourg, Christopher R. LaPensee, Jessica G. Woo, J. Wesley Alexander, Dana C. Borcherding, Thomas J. Byers, A. Clay Clark, Carl Frieden and Keith S. Gersin and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Biochemistry.

In The Last Decade

Eric R. Hugo

29 papers receiving 2.0k citations

Peers

Eric R. Hugo
Terry D. Brandebourg United States
CheMyong Ko United States
Fujun Liu China
Almudena Veiga-López United States
Rosemary Steinmetz United States
Michael C. Henson United States
Donald L. Allen United States
Terry D. Brandebourg United States
Eric R. Hugo
Citations per year, relative to Eric R. Hugo Eric R. Hugo (= 1×) peers Terry D. Brandebourg

Countries citing papers authored by Eric R. Hugo

Since Specialization
Citations

This map shows the geographic impact of Eric R. Hugo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric R. Hugo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric R. Hugo more than expected).

Fields of papers citing papers by Eric R. Hugo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric R. Hugo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric R. Hugo. The network helps show where Eric R. Hugo may publish in the future.

Co-authorship network of co-authors of Eric R. Hugo

This figure shows the co-authorship network connecting the top 25 collaborators of Eric R. Hugo. A scholar is included among the top collaborators of Eric R. Hugo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric R. Hugo. Eric R. Hugo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ben‐Jonathan, Nira, Dana C. Borcherding, & Eric R. Hugo. (2022). Dopamine Receptors in Breast Cancer: Prevalence, Signaling, and Therapeutic Applications. Critical Reviews™ in Oncogenesis. 27(2). 51–71.
2.
Borcherding, Dana C., Wilson Tong, Eric R. Hugo, et al.. (2015). Expression and therapeutic targeting of dopamine receptor-1 (D1R) in breast cancer. Oncogene. 35(24). 3103–3113. 72 indexed citations
3.
Ben‐Jonathan, Nira & Eric R. Hugo. (2014). Prolactin (PRL) in Adipose Tissue: Regulation and Functions. Advances in experimental medicine and biology. 846. 1–35. 68 indexed citations
4.
Hugo, Eric R., et al.. (2014). Placental Lactogen Is Expressed but Is Not Translated into Protein in Breast Cancer. PLoS ONE. 9(1). e87325–e87325. 4 indexed citations
5.
Reyes, Marcela, Nicolás Tobar, Elisa Villalobos, et al.. (2013). Adipogenic effect of calcium sensing receptor activation. Molecular and Cellular Biochemistry. 384(1-2). 139–145. 10 indexed citations
6.
Vandenberg, Laura N., Shelley Ehrlich, Scott M. Belcher, et al.. (2013). Low dose effects of bisphenol A. 1(1). e26490–e26490. 189 indexed citations
7.
Lo, Yuan‐Hung, et al.. (2012). Phosphorylation at tyrosine 114 of Proliferating Cell Nuclear Antigen (PCNA) is required for adipogenesis in response to high fat diet. Biochemical and Biophysical Research Communications. 430(1). 43–48. 12 indexed citations
8.
Borcherding, Dana C., et al.. (2011). Dopamine Receptors in Human Adipocytes: Expression and Functions. PLoS ONE. 6(9). e25537–e25537. 91 indexed citations
9.
Jacobson, Eric M., Eric R. Hugo, Dana C. Borcherding, & Nira Ben‐Jonathan. (2011). Prolactin in breast and prostate cancer: molecular and genetic perspectives.. PubMed. 11(59). 315–24. 28 indexed citations
10.
Cifuentes, Mariana, Pamela Mattar, Nicolás Tobar, et al.. (2010). Obesity-associated proinflammatory cytokines increase calcium sensing receptor (CaSR) protein expression in primary human adipocytes and LS14 human adipose cell line. Archives of Biochemistry and Biophysics. 500(2). 151–156. 33 indexed citations
11.
Jacobson, Eric M., et al.. (2010). Unexploited therapies in breast and prostate cancer: blockade of the prolactin receptor. Trends in Endocrinology and Metabolism. 21(11). 691–698. 31 indexed citations
12.
Ben‐Jonathan, Nira, Eric R. Hugo, & Terry D. Brandebourg. (2009). Effects of bisphenol A on adipokine release from human adipose tissue: Implications for the metabolic syndrome. Molecular and Cellular Endocrinology. 304(1-2). 49–54. 216 indexed citations
13.
Hugo, Eric R., et al.. (2008). Bisphenol A at Environmentally Relevant Doses Inhibits Adiponectin Release from Human Adipose Tissue Explants and Adipocytes. Environmental Health Perspectives. 116(12). 1642–1647. 386 indexed citations
14.
LaPensee, Elizabeth W., et al.. (2007). LS14 cells: A model for chemoresistance in liposarcoma. Cancer Biology & Therapy. 6(4). 519–524. 6 indexed citations
15.
Ben‐Jonathan, Nira, Eric R. Hugo, Terry D. Brandebourg, & Christopher R. LaPensee. (2006). Focus on prolactin as a metabolic hormone. Trends in Endocrinology and Metabolism. 17(3). 110–116. 259 indexed citations
16.
Brandebourg, Terry D., Eric R. Hugo, & Nira Ben‐Jonathan. (2006). Adipocyte prolactin: regulation of release and putative functions. Diabetes Obesity and Metabolism. 9(4). 464–476. 103 indexed citations
17.
LaPensee, Christopher R., Nelson D. Horseman, Patrick Tso, et al.. (2006). The Prolactin-Deficient Mouse Has an Unaltered Metabolic Phenotype. Endocrinology. 147(10). 4638–4645. 45 indexed citations
18.
Hugo, Eric R., Terry D. Brandebourg, Clay E.S. Comstock, et al.. (2005). LS14: A Novel Human Adipocyte Cell Line that Produces Prolactin. Endocrinology. 147(1). 306–313. 66 indexed citations
19.
Byers, Thomas J., et al.. (1991). Molecular Aspects of the Cell Cycle and Encystment of Acanthamoeba. Clinical Infectious Diseases. 13(Supplement_5). S373–S384. 54 indexed citations
20.
Byers, Thomas J., Eric R. Hugo, & Valerie Stewart. (1990). Genes of Acanthamoeba: DNA, RNA and Protein Sequences (A Review)1. The Journal of Protozoology. 37(4). 17S–25S. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026